Ingredion (INGR) attracted fresh attention after reporting second quarter 2026 results with lower earnings and net income, along with reaffirmed full year guidance and an update on flat to slightly higher expected net sales.
See our latest analysis for Ingredion.
Ingredion's recent update on flat to low single digit net sales growth and lower operating income expectations comes as the share price shows modest positive momentum, with a 90 day share price return of 4.84% but a 1 year total shareholder return that declined 13.45%.
If Ingredion's recent move has you thinking about where else capital could work harder, this could be a good moment to scan 21 top founder-led companies
Ingredion trades at a sizeable discount to both analyst targets and one estimate of intrinsic value, yet recent earnings softness has the market hesitant. Does that caution match the fundamentals as they stand today?
Most Popular Narrative: 19.2% Overvalued
The most followed narrative on Ingredion pegs fair value at $88.23, which sits well below the last close of $105.20. That gap raises clear questions about what earnings and margins this view is baking in.
The acquisition of Tate & Lyle has the potential to transform Ingredion from a predominantly commodity-oriented starch and sweetener processor into a more global specialty ingredients platform. The primary upside comes from mix shift toward higher-margin functional ingredients, meaningful cross-selling opportunities with global CPG customers, and scale-driven cost synergies.
Want to see how this transformation story supports a lower fair value than today's price? The narrative leans heavily on measured revenue growth, disciplined margin expansion, and a future earnings multiple that reflects a more specialty focused Ingredion without assuming breakneck growth or aggressive pricing power.
Result: Fair Value of $88.23 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors still need to weigh risks. A tougher integration of Tate & Lyle or weaker returns from Texture & Healthful Solutions could challenge this Ingredion transformation narrative.
Find out about the key risks to this Ingredion narrative.
Another View on Ingredion's Valuation
The narrative fair value of $88.23 suggests Ingredion is 19.2% overvalued. However, the current P/E of 11.2x looks low compared with the US Food industry at 18.2x and peer average at 25.8x, and also below a fair ratio of 17.4x. Could the market be underpricing this earnings stream?
For investors who prefer to lean on simple earnings multiples rather than narratives, the gap between Ingredion's current P/E, its sector, and the fair ratio raises practical questions about valuation risk or opportunity. See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If the push and pull in the Ingredion story leaves you undecided, it makes sense to review the full picture for yourself soon. To see what the market is already optimistic about, start by checking the company's 4 key rewards
Looking for more investment ideas beyond Ingredion?
If you are serious about putting your capital to work, do not stop at Ingredion. The right mix of stocks can help reshape your portfolio.
- Target stability first and put capital to work in companies that score well on resilience with the 80 resilient stocks with low risk scores
- Hunt for pricing power by focusing on companies that look mispriced on quality and valuation in the 52 high quality undervalued stocks
- Build a watchlist of potential future leaders by scanning the screener containing 19 high quality undiscovered gems
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com